Publications
Simultaneous integrated boost of biopsy proven and MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study.
Radiation Oncology. 2, 36.
Singh2007b.pdf (482.13 KB)
(2007). 
Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner.
British Journal of Urology international. 101, 181–185.
Singh2007a.pdf (226.16 KB)
(2007). 
An Interventional MRI Technique for the Molecular Characterization of Intra-Prostatic Dynamic Contrast Enhancement.
Molecular Imaging. 4 No 1, 63-66.
(2005). Transrectal Prostate Biopsy and Fiducial Marker Placement in a Standard 1 5T MRI Scanner.
Annual Meeting of International Society of Magnetic Resonance in Medicine (ISMRM).
(2004).